drugset / Trial / NCT03154541

SynRinse Irrigation Pilot (SIP) Trial

NCT03154541 ↗

Phase 1/2 Completed 30 enrolled University of Washington
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Assess if the use of SYNRINSE can improve short-term subjective and objective outcome measures after one week in patients with active Chronic Rhinosinusitis (CRS) who have had prior sinus surgery.

Timeline

Start
2017-06-06
Primary completion
2018-05-30
Completion
2018-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject SynRinse Other / unclassified — Intranasal